XTX202

· Xilio Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XTX202, covering 2025-05-07 to 2025-05-07. Get the full timeline:

Most recent: Clinical Trial Update: XTX202 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]